Muhammet Emin NALDAN, Pelin AYDIN, Elif AHİSKALİOGLU ORAL, Fatma KARAKOÇ, Duygu KARA

From Respiratory Distress to Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of motor neurons, which results in weakness and atrophy of voluntary skeletal muscles. ALS is the most common form of motor neuron disease (MND). It is currently incurable and treatment is largely limited to supportive care. Family history is associated with an increased risk of ALS. The disease usually does not affect cognitive abilities, but causes muscle weakness. Respiratory function in the early stages of the disease is generally normal, shortness of breath occurs as the disease progresses. This paper has been submitted about ALS patient who was diagnosed and treated in intensive care unit followed by severe respiratory failure.

PDF

___

Orsini M, Oliveira AB, Nascimento OJ, Reis CH, Leite MA, de Souza JA, Pupe C, de Souza OG, Bastos VH, de Freitas MR, Teixeira S, Bruno C, Davidovich E, Smidt B. Amyotrophic Lateral Sclerosis: New Perpectives and Update. Neurol Int. 2015;7(2):5885.

Eisen A. Amyotrophic lateral sclerosis: A 40-year personal perspective. J Clin Neurosci. 2009;16(4):505-12.

Oliveira AS, Pereira RD. Amyotrophic lateral sclerosis: three letters that change the people's life. For ever. Arq Neuropsiquiatr. 2009;67(3A):750-82.

Hirano M. Motor neuron diseases. In: Brust JCM, ed, Current: Diagnosis and Treatment. Philadaelphia: McGraw-Hill. 2011;574.

De Freitas MRG. Esclerose lateral amiotrófica|Doença de Charcot, Melo-Souza S, ed, Tratamento das Doenças Neurológicas. Vila Mariana; Guanabara Koogan; 2013;1324.

Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-9.

Oey PL, Vos PE, Wieneke GH, Wokke JH, Blankestijn PJ, Karemaker JM. Subtle involvement of the sympathetic nervous system in amyotrophic lateral sclerosis. Muscle Nerve. 2002;25(3):402-8.

Miller RD, Mulder DW, Fowler WS, Olsen AM: Exertional dyspnea: a primary complaint in unusual cases of progressive muscular atrophy and amyotrophic lateral sclerosis. Ann Intern Med. 1957;46(1):119-25.

Chen R, Grand'Maison F, Strong MJ, Ramsay DA, Bolton CF: Motor neuron disease presenting as acute respiratory failure: a clinical and pathological study. J Neurol Neurosurg Psychiatry. 1996;60(4):455-8.

Poppe L, Rue L, Robberecht W, Van Den Bosch L. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS). Exp Neurol. 2014 Dec;262 Pt B:138-51.

Carter GT, Krivickas LS, Weydt P, Weiss MD, Miller RG. Drug therapy for amyotrophic lateral sclerosis: Where are we now? IDrugs. 2003;6(2):147-53.

Current clinical trials and underlying pathomechanisms. Nervenarzt. 2008;79(6):653-61.

Meamar R, Nasr-Esfahani MH, Mousavi SA, Basiri K. Stem cell therapy in amyotrophic lateral sclerosis. J Clin Neurosci. 2013;20(12):1659-63.

Thomsen GM, Gowing G, Svendsen S, Svendsen CN. The past, present and future of stem cell clinical trials for ALS. Exp Neurol. 2014;262 Pt B:127-37.